Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (582)	4/12/2002 4:06:59 AM
From: Icebrg	Read Replies (1) \| Respond to of 2240

Psoriasis Patients in Genmab's HuMax-CD4 Phase II Trial Experience Long Lasting Effects Message 17321338

To: Icebrg who wrote (582)	4/18/2002 1:04:32 PM
From: nigel bates	Read Replies (2) \| Respond to of 2240

Parking deals and dates from 10K... 1. Collaborations Date of Agreement ------------------------ ----------------- ZYCOS Inc. January 2002 Tularik Inc. January 2002 Ambit Biosciences Corporation November 2001 m-phasys GmbH November 2001 Incyte Genomics, Inc. October 2001 Epicyte Pharmaceuticals, Inc. July 2001 Sangamo BioSciences, Inc. June 2001 deCODE genetics, Inc. June 2001 Glaucus Proteomics B.V. April 2001 NeuroTherapeutics, Inc. April 2001 Northwest Biotherapeutics, Inc. April 2001 Eos Biotechnology, Inc. February 2001, February 2000 Immusol, Inc. February 2001 Seattle Genetics, Inc. February 2001 Gemini Genomics plc December 2000 Epigen, Inc. November 2000 Oxford GlycoSciences plc September 2000 Athersys, Inc. August 2000 Corixa Corporation June 2000 Regeneron Pharmaceuticals, Inc. March 2000 > 2. Licensing Partnerships Date of Agreement -------------------------- ----------------- <S> <C> Genesto A/S August 2001 Human Genome Sciences, Inc. July 2001 NovImmune, S.A. May 2001 Schering-Plough Corporation March 2001 B. Twelve, Inc. January 2001 Novo Nordisk A/S January 2001 Eli Lilly & Company January 2001, November 2000 ZymoGenetics, Inc. October 2000 Oxford GlycoSciences plc September 2000 Corixa Corporation June 2000 MedImmune, Inc. June 2000 Centocor, Inc. (subsidiary of J&J) May 2000, February 1997 Raven Biotechnologies, Inc. March 2000 Amgen, Inc. September 1999 Eos Biotechnology, Inc. August 1999 Schering AG May 1999, February 1998 Genmab A/S March 1999, August 2000 Millenium Pharmaceuticals, Inc. February 1999, January 1995 Immunex Corporation January 1999 Novartis Pharma AG November 1998 FibroGen, Inc. July 1998 3. Other Collaborations Date of Agreement ------------------------ ----------------- Sangamo BioSciences, Inc. January 2002 Biosite Incorporated June 2000 Kirin Brewery Co., Ltd. December 1999 Aventis Behring, L.L.C. April 1996